I was silent for a long time, but I am tired! Not Grandma’s Nines, but this is the way to get rid of K-19



[ad_1]

Professor Kosta Kostov mentioned one of the ways to deal with the pandemic. According to him, this is a massive test, not only of people with symptoms, but also of those who could be carriers without knowing it.

This is what he wrote on his Facebook account:

“A few months ago, in one of my interviews, I said that the key to a pandemic is … to test, test, test, isolate the positives and find contacts. This is the most effective addition to the other three anti-epidemic measures: mask, distance, disinfection.

If this strategy is not complete and the result will be half empty. Then a strange antiscientific scenario developed, in which the main line was “test only symptoms”. It is as if we are in another galaxy, on another planet, at another time.

With this rapid method, Slovakia halved the number of COVID-19 patients

Extracting a chicken egg from duckweed is a strange Bulgarian scientific method. I was silent for a long time, because for some time I have completely focused on the dozens of patients who need me, but when they persistently keep putting tomatoes in your fruit salad because tomato is a fruit, then you turn the plate over the table.

Control of Kovid-19 requires the broadest possible testing of the population: symptomatic, presymptomatic, and asymptomatic. Let’s get our head out of the sandy bottom once. The great trump card of this new virus against us is its incredible ability to spread through symptomatic and asymptomatic and mildly symptomatic carriers.

The last two groups are the biggest problem because they are not less than 80% of those infected. Grandma’s nines are the common versions to evaluate only symptomatic patients. This is not only scientifically unsustainable, but also a provocation for the protection of public health. The widest possible testing should become a priority in the coming months.

Antigen tests should be given a higher level of confidence because they are rapid and do not require specialized equipment or such qualified personnel. They have another advantage: They have a lower sensitivity and therefore capture a higher viral load, making them a convenient predictor of a possible carrier of an infectious dose.

At the forefront of symptomatic patients, with enormous laboratory workloads and peak epidemic levels, positive antigen testing can be used as equal partners for RT-PCR, saving time and resources.

After a general population test in Slovakia, they decided …

RT-PCR should be used as a judge in symptomatic patients with a negative antigen test and in asymptomatic contacts because they are more sensitive, detect a lower viral load, and can review negative antigen tests to have more resources for testing.

This will save money and time and provide clinicians with more opportunities to act more forcefully and with more restraint for patients and the system, targeting more precisely clinically and epidemiologically. Those infected with a negative antigen test but positive PCR after a symptomatic period are more likely not to spread the virus.

Asymptomatic contact in the first days after contact, with negative antigen test, but with positive PCR it can be in a presymptomatic phase and in the next few days become dangerous for others. A symptom with a positive antigen test and clinical signs of Kovid-19 does not need to be flattered in laboratories to further infect others, but to be recognized as a patient with this diagnosis.

Grant broader rights to heads of Kovid-19 sectors to diagnose Kovid-19 without positive tests available, in order to save the most seriously ill unnecessary paperwork and time, and in patients with a defined clinical course and ray imaging X, to be interpreted correctly and dealt with in a timely manner.

It should be remembered that an infected person is at risk for others from the second day after infection to 10-12 days from the onset of symptoms. Skillful use of clinical and laboratory resources will provide more opportunities for patients and clinicians. ”



[ad_2]